Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/14/1993 | WO1993019805A1 Fibrin sealant delivery method |
10/14/1993 | WO1993019781A1 Vaccines containing non-ionic surfactant vesicles |
10/14/1993 | WO1993019776A1 Protein formulation comprising growth hormone |
10/14/1993 | WO1993019775A1 Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins |
10/14/1993 | WO1993019773A1 Lyophilized somatotropin formulations |
10/14/1993 | WO1993019771A1 Pernasal preparation containing granulocyte colony-stimulating factor |
10/14/1993 | WO1993019769A1 Wound healing and treatment of fibrotic disorders |
10/14/1993 | WO1993019768A1 Self-assembling polynucleotide delivery system |
10/14/1993 | WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/14/1993 | WO1993019755A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | WO1993019753A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
10/14/1993 | WO1993019746A1 Topical administration of toremifene and its metabolites |
10/14/1993 | WO1993019741A1 A pharmaceutical formulation |
10/14/1993 | WO1993019740A1 Methods of manufacturing high dosage glutathione, the tablets and capsules produced thereby |
10/14/1993 | WO1993019739A1 Viscous suspensions of controlled-release drug particles |
10/14/1993 | WO1993019738A1 Method of treatment of infected tissues |
10/14/1993 | WO1993019737A1 A pharmaceutical composition containing a defined lipid system |
10/14/1993 | WO1993019736A1 A pharmaceutical carrier system containing defined lipids |
10/14/1993 | WO1993019735A1 Process for the preparation of microcapsules or liposomes with controlled sizes |
10/14/1993 | WO1993019734A1 Method and composition for treating antigen-induced and exercise-induced asthma |
10/14/1993 | WO1993019733A1 Moisturizer |
10/14/1993 | WO1993019708A1 Transdermal albuterol absorption dosage unit and process |
10/14/1993 | WO1993019700A1 Systems and methods for cell implants |
10/14/1993 | WO1993019698A1 Intra-ruminal devices |
10/14/1993 | WO1993019596A1 Dispersible products |
10/14/1993 | CA2133737A1 Lyophilized somatotropin formulations |
10/14/1993 | CA2133470A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | CA2133109A1 Moisturizer |
10/14/1993 | CA2132726A1 Intra-ruminal devices |
10/14/1993 | CA2132015A1 Tissue implant systems and methods for sustaining viable high cell densities within a host |
10/14/1993 | CA2128621A1 Biodegradable polycarbonates and their use as drug carriers |
10/14/1993 | CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
10/14/1993 | CA2117495A1 Fibrin sealant delivery method |
10/13/1993 | EP0565401A1 Continuous process for making a non-newtonian paste or cream like material |
10/13/1993 | EP0565361A1 Liposome formulation and process for production thereof |
10/13/1993 | EP0565301A1 Prolonged-release liquid type of pharmaceutical preparation |
10/13/1993 | EP0565296A1 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia |
10/13/1993 | EP0565236A2 Colour-coded inactivated vaccines for poultry |
10/13/1993 | EP0565210A2 Vehicles for oral adminstration of pharmaceutically active acide labile substances |
10/13/1993 | EP0565134A1 Disinfecting compositions and methods therefor |
10/13/1993 | EP0564803A1 Use of aminoacids for improving the quality of sleep and treating sleep disorders |
10/13/1993 | EP0564700A1 Pharmaceutical tablet containing white starch |
10/13/1993 | EP0564586A1 Aqueous vaginal douche and related methods |
10/13/1993 | EP0564537A1 Stable suspension formulations for controlled delivery of pharmaceutical compounds |
10/13/1993 | EP0564495A1 Tissue factor based prothrombin time reagent |
10/13/1993 | EP0560937A4 Pharmaceutical compositions |
10/13/1993 | EP0550463A4 Stabilized liposome process and compositions containing them |
10/13/1993 | EP0527942A4 Colonic drug delivery system |
10/13/1993 | EP0353267B1 Emulsion for parenteral administration |
10/13/1993 | EP0271570B1 Use of mullerian inhibiting substance as a contraceptive agent |
10/13/1993 | CN1077130A Ointment for treatment of spur |
10/13/1993 | CN1077121A Preparation of capsule for curing spondylopathy |
10/12/1993 | US5252706 Oligopeptides with protecting groups, a straight-chain or branched alkyl propyl ether; nonleakage |
10/12/1993 | US5252701 Segmented absorbable copolymer |
10/12/1993 | US5252611 Controlled release tablets including strongly swellable, moderately crosslinked polyvinylpyrrolidone |
10/12/1993 | US5252588 Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation |
10/12/1993 | US5252577 Applying a barbiturates |
10/12/1993 | US5252561 Preparation for the controlled release of active substances which are suitable as a therapeutics or for improving growth and feed utilization in ruminants |
10/12/1993 | US5252557 With sodium hyaluronate |
10/12/1993 | US5252542 Controlled release composition and method for using |
10/12/1993 | US5252348 Double detergent dialysis techniques |
10/12/1993 | US5252341 Tablets and granulates containing mesna as active substance |
10/12/1993 | US5252339 Pharmaceutical compositions containing orally absorbable glycosamimoglycans |
10/12/1993 | US5252338 Therapy delayed |
10/12/1993 | US5252337 Heating loaded pellets in a dispersion of ethyl cellulose in an organic solvent; cooling to solidify the dissolved cellulose |
10/12/1993 | US5252336 Liposome composition whose liposome membrane contains a polyoxyethylene derivative |
10/12/1993 | US5252335 Transdermal administration of lisuride |
10/12/1993 | US5252334 Solid matrix system for transdermal drug delivery |
10/12/1993 | US5252333 Lithium salt-containing pharmaceutical compositions |
10/12/1993 | US5252327 Solutions containing antigen and zinc hydroxide or iron hydroxide as an adjuvant and processes for preparing such solutions |
10/12/1993 | US5252319 Aminosteroids for ophthalmic use |
10/12/1993 | US5252318 Reversible gelation compositions and methods of use |
10/12/1993 | US5252263 Liposomes having internal acidic aqueous buffer are treated with alkaline buffer to yield external bilayer with ionizable lipid or protein |
10/12/1993 | US5252246 Detergents for cleaning sensitive tissues such as eyes |
10/12/1993 | US5252222 Synthetic microporous polymeric structure |
10/12/1993 | CA1322957C Cyclic amp derivative ointments |
10/10/1993 | CA2093454A1 Method for improving the quality of sleep and treating sleep disorders |
10/08/1993 | CA2093381A1 Liposome formulation and process for production thereof |
10/07/1993 | DE4230588C1 Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung Dexpanthenol-containing patch for transdermal administration of steroid hormones and process for its preparation |
10/06/1993 | EP0564307A1 Antiskin rash preparation |
10/06/1993 | EP0564277A1 Moisturing cosmetic compositions |
10/06/1993 | EP0564154A1 A pharmaceutical formulation in the form of aqueous suspension |
10/06/1993 | EP0563876A2 Biodegradable microbeads for the pharmaceutical and cosmetic uses |
10/06/1993 | EP0563813A1 Transdermal compositions |
10/06/1993 | EP0563697A2 Cytarabine ocfosfate hard capsule |
10/06/1993 | EP0563507A1 Transdermal patch incorporating a polymer film incorporated with an active agent |
10/06/1993 | EP0563389A1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
10/06/1993 | EP0563302A1 Method and apparatus for granulation |
10/06/1993 | EP0563227A1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein. |
10/06/1993 | EP0563112A1 Enhanced bioavailability pharmaceutical composition containing probucol. |
10/06/1993 | EP0563048A1 Aerosol formulations |
10/06/1993 | EP0525055A4 Improved iontophoretic administration of drugs |
10/06/1993 | EP0514435B1 Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it |
10/06/1993 | EP0452384B1 Fentanyl containing aerosol compositions |
10/06/1993 | CN2143111Y Pill for cervical erosion |
10/06/1993 | CN1076861A Fragrant inhalation for preventing and treating cold and its preparation |
10/05/1993 | US5250584 Porous, biodegradable, absorbable films or sheets of high molecular weight polylactone copolymers for protective coverings during healing of dental injuries or surgery |
10/05/1993 | US5250569 Slow release hard candy containing complex of aluminum compound and amino acid from group of glycine, alanine, amoinobutyric acid/2-/, valine, isovaline, leucine, lysine |
10/05/1993 | US5250302 A DNA sequence encoding a polypeptide which together with a matrix induces endochondral bone formation in mammals |
10/05/1993 | US5250301 Method for treating digestive organ disorders |